FDA Adverse Event Injury Summary report: N

HAKIM PROGRAMMABLE VALVE

MDR report key: 3150601 · Received June 6, 2013

Report

Report Number
1226348-2013-18313
Event Type
Injury
Date Received
June 6, 2013
Date of Event
May 15, 2013
Manufacturer
CODMAN & SHURTLEFF, INC.
Product Code
JXG
PMA / PMN Number
PK992173
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON COMPLETION OF THE INVESTIGATION IT WAS NOTED THE VALVE WAS VISUALLY INSPECTED AND CONFIRMED THE TEAR IN THE SILICONE HOUSING. ALTHOUGH IT IS NOT POSSIBLE TO DETERMINE THE ROOT CAUSE FOR THE TEAR IN THE HOUSING, IT MIGHT BE POSSIBLE THAT THE DEVICE CAME IN CONTACT WITH A SHARP OR POINTED OBJECT DURING THE IMPLANT OR EXPLANTS OF THE DEVICE, THIS HOWEVER COULD NOT BE DETERMINED. IT WAS ALSO NOTED THAT THE CATHETER WAS NOT RETURNED FOR INVESTIGATION. A REVIEW OF THE HISTORY DEVICE RECORDS FOR THE VALVE CONFIRMED THE VALVE CONFORMED TO THE SPECIFICATIONS WHEN RELEASED TO STOCK. THE LOT RECORDS COULD NOT BE REVIEWED FOR THE CATHETER AS THE LOT NUMBER WAS NOT PROVIDED. THE INSTRUCTIONS FOR USE WARNS HEALTH CARE USERS TO USE EXTREME CARE WHEN HANDLING SILICONE PRODUCTS AS SILICONE HAS A LOW TEAR RESISTANCE. BASED ON THE RESULTS OF THIS INVESTIGATION NO FURTHER ACTION IS REQUIRED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CLOSED.

Additional Manufacturer Narrative · 1

UPON COMPLETION OF THE INVESTIGATION, A FOLLOW UP REPORT WILL BE FILED. WE DO NOT USE THERAPY DATES. AS A RESULT, TODAY'S DATE WAS USED.

Description of Event or Problem · 1

THE AFFILIATE REPORTED THAT AFTER IMPLANTATION, FLUID ACCUMULATION WAS NOTED. THE DEVICE WAS REPLACED DUE TO SILICONE HOUSING BREAKAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
251437 HAKIM PROGRAMMABLE VALVE SHUNT, CENTRAL NERVOUS SYSTEM, & COMPS JXG CODMAN & SHURTLEFF, INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention (B)(4)